Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-006473
Filing Date
2025-01-17
Accepted
2025-01-17 06:02:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6475
  Complete submission text file 0000950170-25-006473.txt   8140
Mailing Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200
Business Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 0000

Mailing Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Subject) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88275 | Film No.: 25536894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)